Vericel COO sells 10,305 shares under 10b5-1 plan

Vericel Corp's Chief Operating Officer, Michael Halpin, sold 10,305 shares of common stock in an open-market transaction at $35.30 per share on March 2, 2026.

Rhea-AI Filing Summary

Vericel Corp's Chief Operating Officer, Michael Halpin, sold 10,305 shares of common stock in an open-market transaction at $35.30 per share on March 2, 2026. The sale was executed automatically under a Rule 10b5-1 trading plan he adopted on December 2, 2025, leaving him with 16,080 directly owned shares.

Insider Trade Summary

Net Seller: 10,305 shares

Net Sell 1 txn

Insider Halpin Michael

Role Chief Operating Officer

Sold 10,305 shs ($364K)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,305	$35.30	$364K

Holdings After Transaction: Common Stock — 16,080 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
2. F2. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vericel (VCEL) report for Michael Halpin?

Vericel reported that Chief Operating Officer Michael Halpin sold 10,305 shares of common stock. The shares were sold in an open-market transaction at $35.30 per share, and the transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

When did Vericel COO Michael Halpin sell his VCEL shares and at what price?

Michael Halpin sold his Vericel shares on March 2, 2026 at a price of $35.30 per share. The sale involved 10,305 shares of common stock and was reported as an open-market or private transaction on a Form 4 filing.

How many Vericel shares does Michael Halpin hold after the reported Form 4 sale?

After the reported sale, Michael Halpin directly owns 16,080 Vericel common shares. This figure reflects his holdings following the 10,305-share open-market sale executed on March 2, 2026 under his Rule 10b5-1 trading plan adopted in December 2025.

Was Michael Halpin’s Vericel stock sale under a Rule 10b5-1 trading plan?

Yes. The filing states the sales were effected automatically under a Rule 10b5-1 trading plan adopted by Michael Halpin on December 2, 2025. Such plans allow insiders to schedule future trades pursuant to pre-set instructions, independent of later material nonpublic information.

What type of security did Michael Halpin sell in the Vericel Form 4 filing?

Michael Halpin sold Vericel common stock, classified as a non-derivative security in the Form 4. The transaction code was “S,” indicating a sale in the open market or a private transaction, with 10,305 shares sold at $35.30 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:05 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Halpin Michael

(Last) (First) (Middle)

64 SIDNEY STREET

(Street)

CAMBRIDGE MA 02139

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		S		10,305	D(1)	$35.3	16,080(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

2. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

	/s/ Sean Flynn, as Attorney-in-Fact for Michael Halpin	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.